Assessment of Diaphragmatic Function After Stellate Ganglion Block
Diaphragmatic Ultrasound and Spirometry After Ultrasound-guided Stellate Ganglion Block: a Prospective Observational Study
1 other identifier
observational
15
1 country
1
Brief Summary
The objective of our study was to evaluate the incidence of hemidiaphragmatic paralysis after ultrasound-guided stellate ganglion block (US-SGB) by assessing diaphragmatic excursion and diaphragmatic thickening fraction using diaphragm ultrasound.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
CompletedFirst Submitted
Initial submission to the registry
July 15, 2026
CompletedFirst Posted
Study publicly available on registry
July 23, 2026
CompletedJuly 23, 2026
July 1, 2026
1 year
July 15, 2026
July 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Diaphragmatic excursion
Excursion of the diaphragmatic dome was assessed by a pulmonologist experienced in diaphragm ultrasound assessment. Once the dome was identified, excursion was measured in M-mode as the distance, in centimeters, between the end-expiratory and end-inspiratory positions during a vital capacity manoeuvre.
The diaphragmatic excursion, assessed by diaphragm ultrasound before and 30 minutes after US-SGB.
Diaphragmatic thickening fraction
The diaphragmatic thickening fraction was assessed by a pulmonologist experienced in diaphragm ultrasound assessment. Diaphragm thickness was measured, in centimeters, at end-inspiration and end-expiration during a vital capacity manoeuvre. Thickening fraction was calculated using the following formula and expressed as a percentaje: Thickening fraction = \[(thickness at end-inspiration - thickness at end-expiration) / thickness at end-expiration\] x 100.
The diaphragmatic thickening, assessed by diaphragm ultrasound before and 30 minutes after US-SGB.
Secondary Outcomes (4)
Forced vital capacity (FVC)
Spirometric parameters measured at baseline and 1 hour after US-SGB.
Forced expiratory volume in 1 second (FEV1)
Spirometric parameters measured at baseline and 1 hour after US-SGB.
Tiffeneau index (FEV1/FVC ratio)
Spirometric parameters measured at baseline and 1 hour after US-SGB.
Peripheral oxygen saturation (SpO2)
Measured at baseline and 1 hour after US-SGB.
Study Arms (1)
US-SGB
Patients with sympathetic nervous system-mediated disorders of the upper limb undergoing a first diagnostic ultrasound-guided stellate ganglion block (US-SGB).
Interventions
US-SGB was performed at the C7 level using 10 ml of 0.25% levobupivacaíne.
Eligibility Criteria
After approval of the study by the Principality of Asturias Drug Research Ethics Committee (CEImPA), Spain, and obtaining informed consent from the participants, all consecutive patients undergoing a first diagnostic US-SGB for sympathetic nervous system-mediated disorders were prospectively included.
You may qualify if:
- patients over 18 years of age.
- patients with sympathetic nervous system-mediated disorders.
You may not qualify if:
- patients younger than 18 years of age.
- patients with severe chronic obstructive pulmonary disease.
- previous diaphragmatic paralysis or neuromuscular disease.
- inability to undergo diaphragmatic ultrasound.
- patients with neck anatomy considered unsuitable for the procedure (including previous neck surgery, burns, extensive scarring or large goiters resulting in distortion of normal cervical anatomy).
- contraindications to the interventional technique (such as infection at the puncture site, or refusal to provide consent).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
FINBA
Oviedo, Principality of Asturias, 33001, Spain
Related Publications (6)
Rafla C, Zitek T, Shalaby M. A systematic review of the respiratory effects of ultrasound-guided phrenic nerve block. Anesth Pain Med (Seoul). 2025 Oct;20(4):371-383. doi: 10.17085/apm.25214. Epub 2025 Sep 26.
PMID: 41035293RESULTSantana PV, Cardenas LZ, Albuquerque ALP, Carvalho CRR, Caruso P. Diaphragmatic ultrasound: a review of its methodological aspects and clinical uses. J Bras Pneumol. 2020 Nov 20;46(6):e20200064. doi: 10.36416/1806-3756/e20200064. eCollection 2020.
PMID: 33237154RESULTSferrazza Papa GF, Pellegrino GM, Di Marco F, Imeri G, Brochard L, Goligher E, Centanni S. A Review of the Ultrasound Assessment of Diaphragmatic Function in Clinical Practice. Respiration. 2016;91(5):403-11. doi: 10.1159/000446518. Epub 2016 May 25.
PMID: 27216909RESULTTsai EH, Nunez-Rodriguez E, Cata JP. Stellate ganglion block in perioperative practice: a narrative review. Br J Anaesth. 2026 Jan;136(1):179-196. doi: 10.1016/j.bja.2025.07.095. Epub 2025 Sep 29.
PMID: 41027820RESULTMotazedian P, Quinn N, Wells GA, Beauregard N, Lam E, Mathieu ME, Knoll W, Prosperi-Porta G, Ly V, Parlow S, Di Santo P, Abdel-Razek O, Jung R, Simard T, Jentzer JC, Mathew R, Ramirez FD, Hibbert B. Efficacy of stellate ganglion block in treatment of electrical storm: a systematic review and meta-analysis. Sci Rep. 2024 Oct 21;14(1):24719. doi: 10.1038/s41598-024-76663-9.
PMID: 39433834RESULTKirkpatrick K, Khan MH, Deng Y, Shah KB. A Review of Stellate Ganglion Block as an Adjunctive Treatment Modality. Cureus. 2023 Feb 19;15(2):e35174. doi: 10.7759/cureus.35174. eCollection 2023 Feb.
PMID: 36949968RESULT
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel García Iglesias, MD, PhD
Central University Hospital of Asturias, 33001, Spain
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD. Consultant Anesthesiologist and Pain Physician
Study Record Dates
First Submitted
July 15, 2026
First Posted
July 23, 2026
Study Start
December 1, 2024
Primary Completion
December 10, 2025
Study Completion
June 1, 2026
Last Updated
July 23, 2026
Record last verified: 2026-07